In line with these findings, we demonstrate that TGFBR2 is expressed at higher levels in more aggressive basal‐like breast cancer cell lines as well as in triple‐negative breast cancer tissue than in luminal breast cancer cell lines and luminal‐like tumor tissue. Here, TGFBR2 is linked to breast carcinoma.